169 related articles for article (PubMed ID: 31371518)
1. CCL21 Expression in β-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice.
Gonzalez Badillo FE; Zisi Tegou F; Abreu MM; Masina R; Sha D; Najjar M; Wright SH; Bayer AL; Korpos É; Pugliese A; Molano RD; Tomei AA
Diabetes; 2019 Oct; 68(10):1990-2003. PubMed ID: 31371518
[TBL] [Abstract][Full Text] [Related]
2. CCL21 and beta-cell antigen releasing hydrogels as tolerance-inducing therapy in Type I diabetes.
Zisi Tegou F; Velluto D; Stock AA; Fitzgerald SN; Stealey S; Zustiak SP; Bayer AL; Tomei AA
J Control Release; 2022 Aug; 348():499-517. PubMed ID: 35691500
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes.
Korpos É; Kadri N; Loismann S; Findeisen CR; Arfuso F; Burke GW; Richardson SJ; Morgan NG; Bogdani M; Pugliese A; Sorokin L
Diabetologia; 2021 Jul; 64(7):1626-1641. PubMed ID: 33912981
[TBL] [Abstract][Full Text] [Related]
4. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
5. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.
Henry RA; Kendall PL
J Immunol; 2010 Aug; 185(3):1460-5. PubMed ID: 20574003
[TBL] [Abstract][Full Text] [Related]
6. Expression of CCL21 and 5'-Nase on pancreatic lymphatics in nonobese diabetic mice.
Qu P; Ji RC; Kato S
Pancreas; 2005 Aug; 31(2):148-55. PubMed ID: 16025002
[TBL] [Abstract][Full Text] [Related]
7. CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice.
Shan Z; Xu B; Mikulowska-Mennis A; Michie SA
Immunol Res; 2014 May; 58(2-3):351-7. PubMed ID: 24687731
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Penaranda C; Tang Q; Ruddle NH; Bluestone JA
Diabetes; 2010 Jun; 59(6):1461-8. PubMed ID: 20299465
[TBL] [Abstract][Full Text] [Related]
9. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
10. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
[TBL] [Abstract][Full Text] [Related]
11. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
12. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.
Mueller R; Krahl T; Sarvetnick N
J Exp Med; 1996 Sep; 184(3):1093-9. PubMed ID: 9064326
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
15. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
16. Transgenic substitution with Greater Amberjack Seriola dumerili fish insulin 2 in NOD mice reduces beta cell immunogenicity.
Foo KS; Skowronski AA; Baum D; Firdessa-Fite R; Thams S; Shang L; Creusot RJ; LeDuc CA; Egli D; Leibel RL
Sci Rep; 2019 Mar; 9(1):4965. PubMed ID: 30899071
[TBL] [Abstract][Full Text] [Related]
17. PI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levels.
Zotes TM; Spada R; Mulens V; Pérez-Yagüe S; Sorzano CO; Okkenhaug K; Carrera AC; Barber DF
PLoS One; 2013; 8(8):e72960. PubMed ID: 24009720
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated pancreatic overexpression of
Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
20. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
